The Trump administration yesterday released its budget proposal for the 2019 fiscal year, and it would cut the US Centers for Disease Control and Prevention (CDC) budget by about $900 million, with some increases for the National Institutes of Health (NIH) and the US Food and Drug Administration (FDA).
A series of papers yesterday in Infection Control and Hospital Epidemiology by researchers and clinicians with the Veterans Health Administration (VHA) identifies key knowledge gaps and lays out research agendas to address the spread of drug-resistant pathogens in healthcare settings.
Allergan, a pharmaceutical company based in Dublin, Ireland, yesterday announced that the US Food and Drug Administration (FDA) has approved an expanded indication for its antibiotic combination drug Avycaz (ceftazidime and avibactam) to treat hospital-acquired bacterial pneumonia (HABP) and ventilator-associated bacterial pneumonia (VABP) caused by gram-negative organisms.
Preliminary indications into South Sudan's recent viral hemorrhagic fever outbreak suggest that Rift Valley fever (RVF) may be the cause, the World Health Organization (WHO) Regional Office for Africa said in its latest outbreak and health emergencies update.
A phase 3 trial shows ceftazidime-avibactam "non-inferior" to meropenem.
The Saudi Arabian Ministry of Health (MOH) today reported a new case of MERS-CoV in Bisha, the third within the last week.
A 67-year-old Saudi woman is in stable condition after presenting with symptoms of MERS-CoV (Middle East respiratory syndrome coronavirus) infection. Her source of infection is listed as "primary," meaning it's unlikely she contracted the virus from another person.
Fever, crackling in the lungs, high pulse, and low blood oxygen may be predictive.
More than two thirds of adult hospital patients are on the drugs longer than needed.
Using just 1 drug instead of 2 could go a long way in curbing azithromycin use.
Influenza is finally on the decline in Australia, according to yesterday's global flu update from the World Health Organization (WHO). Influenza A, H3N2, remained the dominant circulating strain, followed by influenza B.
